Adagio Medical Holdings, Inc (ADGM)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$0.1950−$0.0150 (−7.14%) on the dayAs of the close; data may be delayed.
ADGM price, last 12 months
Key stats
- Previous close
- $0.2100
- Open
- $0.2160
- Day range
- $0.1850 – $0.2200
- 52-week range
- $0.1755 – $2.58
- Volume
- 2.1M
- Avg volume (20 days)
- 2.4M
- Market cap
- $4.3M
Performance
1W−59.6%
1M−62.6%
3M−69.8%
6M−84.3%
YTD−81.3%
1Y−90.9%
vs S&P 500, 1Y−107.7 pts
Technicals and fundamentals
About Adagio Medical Holdings, Inc
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $4.3M